PLoS Pathogens (Apr 2009)

A critical role for CD8 T cells in a nonhuman primate model of tuberculosis.

  • Crystal Y Chen,
  • Dan Huang,
  • Richard C Wang,
  • Ling Shen,
  • Gucheng Zeng,
  • Shuyun Yao,
  • Yun Shen,
  • Lisa Halliday,
  • Jeff Fortman,
  • Milton McAllister,
  • Jim Estep,
  • Robert Hunt,
  • Daphne Vasconcelos,
  • George Du,
  • Steven A Porcelli,
  • Michelle H Larsen,
  • William R Jacobs,
  • Barton F Haynes,
  • Norman L Letvin,
  • Zheng W Chen

DOI
https://doi.org/10.1371/journal.ppat.1000392
Journal volume & issue
Vol. 5, no. 4
p. e1000392

Abstract

Read online

The role of CD8 T cells in anti-tuberculosis immunity in humans remains unknown, and studies of CD8 T cell-mediated protection against tuberculosis in mice have yielded controversial results. Unlike mice, humans and nonhuman primates share a number of important features of the immune system that relate directly to the specificity and functions of CD8 T cells, such as the expression of group 1 CD1 proteins that are capable of presenting Mycobacterium tuberculosis lipids antigens and the cytotoxic/bactericidal protein granulysin. Employing a more relevant nonhuman primate model of human tuberculosis, we examined the contribution of BCG- or M. tuberculosis-elicited CD8 T cells to vaccine-induced immunity against tuberculosis. CD8 depletion compromised BCG vaccine-induced immune control of M. tuberculosis replication in the vaccinated rhesus macaques. Depletion of CD8 T cells in BCG-vaccinated rhesus macaques led to a significant decrease in the vaccine-induced immunity against tuberculosis. Consistently, depletion of CD8 T cells in rhesus macaques that had been previously infected with M. tuberculosis and cured by antibiotic therapy also resulted in a loss of anti-tuberculosis immunity upon M. tuberculosis re-infection. The current study demonstrates a major role for CD8 T cells in anti-tuberculosis immunity, and supports the view that CD8 T cells should be included in strategies for development of new tuberculosis vaccines and immunotherapeutics.